Details of the Drug Formulaction

General Information of Drug Formulation (ID: F05202)

• Formulation Name: Dabrafenib 50 mg capsule
• Company: GlaxoSmithKline; Novartis Pharmaceuticals Corporation

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Dabrafenib	(DMX6OE3)	Melanoma	2C30	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Eisenoxyd	(E00585)	56841934	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent